Brokerages Set Silence Therapeutics plc (NASDAQ:SLN) Price Target at $40.67
Silence Therapeutics plc (NASDAQ:SLN – Get Free Report) has earned an average rating of “Moderate Buy” from the seven ratings firms that are presently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation and six have assigned a buy recommendation to the company. The average twelve-month price objective among […]
Silence Therapeutics plc (NASDAQ:SLN – Get Free Report) has earned an average rating of “Moderate Buy” from the seven ratings firms that are presently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation and six have assigned a buy recommendation to the company. The average twelve-month price objective among […]